The role of next-generation sequencing in detecting gene fusions with known and unknown partners: a single-center experience with methodologies’ integration-Reference-Cited by-同舟云学术

The role of next-generation sequencing in detecting gene fusions with known and unknown partners: a single-center experience with methodologies’ integration

Published:2022-05 Issue: Volume:123 Page:20-30
ISSN:0046-8177
Container-title:Human Pathology
language:en
Short-container-title:Human Pathology

Author:

Ambrosini-Spaltro Andrea^ORCID,Farnedi Anna,Calistri Daniele,Rengucci Claudia,Prisinzano Giovanna,Chiadini Elisa,Capelli Laura,Angeli Davide^ORCID,Bennati Chiara,Valli Mirca,De Luca Giovanni,Caruso Dora^ORCID,Ulivi Paola,Rossi Giulio

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference42 articles.

1. Oncogene addiction: pathways of therapeutic response, resistance, and road maps toward a cure;Pagliarini;EMBO Rep,2015

2. Targeting molecular addictions in cancer;Vivanco;Br J Cancer,2014

3. Fusions in solid tumours: diagnostic strategies, targeted therapy, and acquired resistance;Schram;Nat Rev Clin Oncol,2017

4. Overview of clinicopathologic features of ALK-rearranged lung adenocarcinoma and current diagnostic testing for ALK rearrangement;Kim;Transl Lung Cancer Res,2015

5. The EML4-ALK fusion gene is involved in various histologic types of lung cancers from nonsmokers with wild-type EGFR and KRAS;Wong;Cancer,2009

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RABEP1::RET in a Malignant Peripheral Nerve Sheath Tumor of a Pediatric Patient With Neurofibromatosis Type 1;International Journal of Surgical Pathology;2024-05-20

2. Targeting RET alterations in non-small cell lung cancer;Current Problems in Cancer;2024-04

3. RET Fusion Testing in Patients With NSCLC: The RETING Study;JTO Clinical and Research Reports;2024-04

4. Prevalence of a BRCA2 Pathogenic Variant in Hereditary-Breast-and-Ovarian-Cancer-Syndrome Families with Increased Risk of Pancreatic Cancer in a Restricted Italian Area;Cancers;2023-04-03

5. Robust Performance of the Novel Research-Use-Only Idylla GeneFusion Assay Using a Diverse Set of Pathological Samples with a Proposed 1-Day Workflow for Advanced NSCLC Evaluation;Cancers;2022-12-31